Back to SO Squarepoint Ops LLC

TGTXTGTX

Showing 8 of 23 quarters

Position history for SOSquarepoint Ops LLC's holdings in TG THERAPEUTICS INC

Yes. Squarepoint Ops holds 166,975 shares of TGTX (TG Therapeutics), worth $9.2M, as of its Q2 2026 13F filing. It reduced the position by 346,838 shares (-67.5%) from Q1 2026. Squarepoint Ops has held TGTX since Q3 2025, across 4 quarterly 13F filings.

Current Value

$9.2M

Current Shares

166,975

Total Value Change

+$8M

Total Shares Change

+118,262

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
166,975
-67.5%
$9.2M0.0%$54.94
0
2026-Q1
Decreased
513,813
-39.7%
$17.1M0.0%$33.22
0
2025-Q4
Increased
852,522
+68.9%
$25.4M0.0%$29.81
42
2025-Q3
New
504,634
—
$18.2M0.0%$36.13
39
2025-Q2
Exited
0
-100.0%
$00.0%$35.99
0
2025-Q1
Increased
319,226
+51.4%
$12.6M0.0%$39.43
39
2024-Q4
Increased
210,795
+332.7%
$6.3M0.0%$30.10
44
2024-Q3
Decreased
48,713
-5.8%
$1.1M0.0%$23.39
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used